Grants & Institutional Support
Help close medication-affordability gaps that existing programs cannot always reach
Public benefits, insurance, manufacturer assistance, nonprofit programs, health-system resources, and other prescription-help options can make a major difference. Prescription Bridge is designed to help people find and use those resources first, then identify legitimate affordability needs that may remain.
Our existing-resources-first commitment:
Prescription Bridge does not duplicate government prescription benefits. We help people find and use every existing source of assistance available to them first. When those resources cannot solve the problem, Prescription Bridge works to close the remaining affordability gap through charitable resources.
We complement existing programs
Institutional support can strengthen—not unnecessarily duplicate—the medication-access system
Prescription Bridge is designed to complement government prescription benefits, insurance coverage, manufacturer assistance, nonprofit resources, community programs, health-system assistance, and other legitimate medication-access resources. We want people to make effective use of assistance that already exists before charitable Prescription Bridge funding is considered.
That distinction matters: support for Prescription Bridge can help improve awareness, navigation, coordination, community access, responsible infrastructure, and the ability to address eligible gaps that remain. It is not a request to replace benefits or pay privately for costs another available program should cover.
How we measure impact
Build measurement around real, documented outcomes—not inflated claims
As Prescription Bridge grows, we intend to measure appropriate aggregate and de-identified indicators such as people seeking assistance, navigation interactions, people connected with existing resources, successful referrals where known, types of resources identified, remaining affordability gaps identified, charitable assistance delivered where applicable, geographic reach, community partnerships, common categories of medication-access barriers, and program responsiveness.
Before reliable real-world metrics exist, we describe the measurement approach rather than inventing results. Public reporting should protect privacy and should not expose personally identifiable health or assistance information.
Learning from recurring barriers
Use de-identified patterns to improve navigation and program design
Aggregated, de-identified information from the work may help Prescription Bridge understand recurring barriers such as difficulty finding assistance, eligibility obstacles, incomplete coverage, administrative complexity, resource fragmentation, or affordability gaps that remain after existing options are explored. Where appropriate, those lessons can inform better navigation, partnerships, outreach, and future program design.
This does not turn Prescription Bridge into a lobbying organization, a government-surveillance system, or a commercial data broker. Any data collection and reporting must remain consistent with our privacy and data-minimization rules.